Trial · NCT05353348
Effect of the Combined Programme on Perioperative Anaemia（CPPA）
NCT05353348, Not applicable, Recruiting, Second Affiliated Hospital, Zhejiang University, School of Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of the Combined Programme on Perioperative Anaemia（CPPA）. Trials, record NCT05353348. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05353348
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of the Combined Programme on Perioperative Anaemia（CPPA）
- NCT number
- NCT05353348
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 110 participants, estimated
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Conditions
- Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia
- Interventions
- Iron Sucrose, recombinant human erythropoietin, ascorbic acid, conventional treatment
- First posted
- 2022-04-29
- Last updated
- 2025-01-10
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Haemoglobin level on postoperative day 5 | Haemoglobin level on postoperative day 5 | Haemoglobin level on postoperative day 5 |
| Secondary | Amount of allogeneic blood products used in the perioperative period | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | (red blood cells, plasma, platelets) |
| Secondary | Effect of combination therapy on changes in perioperative haemoglobin levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Pre-intervention versus post-operative haemoglobin |
| Secondary | Effect of combination therapy on changes in perioperative ferritin levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Pre-intervention versus post-operative ferritin |
| Secondary | Effect of combination therapy on changes in perioperative reticulocyte levels | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Magnitude of reticulocyte elevation |
| Secondary | Incidence of perioperative acute renal insufficiency | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Postoperative creatinine more than 2 times higher than preoperative or oliguria (\<0.5ml/kg/h) within 12 hours |
| Secondary | Post-operative intensive care unit stay | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Length of stay in ICU after surgery |
| Secondary | Infusion reactions and allergies | From the start of surgery until hospital discharge or postoperative day 30, whichever comes first | Perioperative allergic events |
| Secondary | Incidence of serious adverse events (SAEs) in the perioperative period up to 6 months after surgery | Through study completion, an average of 1.5 year | Myocardial infarction、Ischemic cerebral infarction、arrhythmia、Deep vein thrombosis of the lower extremity、Pulmonary embolism, etc |
| Secondary | All-cause mortality within 6 months of surgery | Through study completion, an average of 1.5 year | Incidence of mortality |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05353348
GET https://conductscience.org/api/trials/v1/NCT05353348/registered